Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:I-203-I-206
doi: 10.1161/01.cir.0000032909.33237.f8
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hausmann, H.
Right arrow Articles by Hetzer, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hausmann, H.
Right arrow Articles by Hetzer, R.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Failure

(Circulation. 2002;106:I-203.)
© 2002 American Heart Association, Inc.


Thoracic Transplantation and Mechanical Support for Congestive Heart Failure

Prognosis After the Implantation of an Intra-Aortic Balloon Pump in Cardiac Surgery Calculated With a New Score

Harald Hausmann, MD; Evgenij V. Potapov, MD; Andreas Koster, MD; Thomas Krabatsch, MD; Julia Stein; Ruhi Yeter, MD; Marian Kukucka, MD; Ralf Sodian, MD; Hermann Kuppe, MD, PhD; Roland Hetzer, MD, PhD

From the Deutsches Herzzentrum Berlin, Berlin, Germany.

Correspondence to Harald Hausmann, MD, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. E-mail: hhausmann{at}dhzb.de

Abstract

Background Over the past decade, the use of a ventricular-assist device (VAD) in patients with postcardiotomy cardiogenic shock has resulted in hospital discharge rates of 25% to 40% and is improving. Nevertheless, indications for and timing of the implantation of a VAD in patients who have received an intra-aortic balloon pump (IABP) remain unclear.

Methods and Results From July 1996 to March 2000, 391 patients with cardiac low-output syndrome who underwent open-heart surgery and had an IABP implanted were analyzed in a retrospective pilot study. The perioperative mortality was 34% (133 patients). Clinical parameters were analyzed 1 hour after IABP support began. Statistical multivariate analysis showed that patients with an adrenaline requirement higher than 0.5 µg · kg-1 · min-1, a left atrial pressure >15 mm Hg, urine output <100 mL/h, and mixed venous saturation (SVO2) <60% had poor outcomes. Using this data, we developed an IABP score (0 to 5 points) to predict survival early after IABP implantation in cardiac surgery. We evaluated our score by monitoring another 101 patients as a control group prospectively. Additionally, 210 patients who received coronary artery bypass grafting (CABG) exclusively were analyzed. All investigations confirmed the validity of the score.

Conclusions The IABP score can predict survival early after IABP implantation. In patients with a high IABP score, implantation of a VAD should be considered.


Key Words: heart failure • heart-assist device • cardiopulmonary bypass




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
W. Bedda and N. Doll
Invited commentary.
Ann. Thorac. Surg., December 1, 2009; 88(6): 1904 - 1904.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. W. Haft, F. D. Pagani, M. A. Romano, C. L. Leventhal, D. B. Dyke, and J. C. Matthews
Short- and long-term survival of patients transferred to a tertiary care center on temporary extracorporeal circulatory support.
Ann. Thorac. Surg., September 1, 2009; 88(3): 711 - 717.
[Abstract] [Full Text] [PDF]